Predictmedix AI Management

Management Kriterienprüfungen 0/4

Wir verfügen derzeit nicht über ausreichende Informationen über den CEO.

Wichtige Informationen

Geschäftsführender

n/a

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts	n/a
Amtszeit als Geschäftsführer	no data
Eigentum des Geschäftsführers	n/a
Durchschnittliche Amtszeit des Managements	keine Daten
Durchschnittliche Amtszeit der Vorstandsmitglieder	keine Daten

Jüngste Management Updates

Shareholders Will Probably Not Have Any Issues With Predictmedix AI Inc.'s (CSE:PMED) CEO Compensation

Dec 08

Recent updates

Shareholders Will Probably Not Have Any Issues With Predictmedix AI Inc.'s (CSE:PMED) CEO Compensation

Dec 08

Geschäftsführer

Predictmedix AI hat keinen Geschäftsführer, oder es liegen keine verfügbaren Daten vor.

Predictmedix AI Management

Management Kriterienprüfungen 0/4

Wichtige Informationen

Jüngste Management Updates

Shareholders Will Probably Not Have Any Issues With Predictmedix AI Inc.'s (CSE:PMED) CEO Compensation

Predictmedix AI Inc., Annual General Meeting, Dec 07, 2023

Less than half of directors are independent

High number of new directors

High number of new and inexperienced directors

High number of new and inexperienced directors

Recent updates

New minor risk - Shareholder dilution

New major risk - Negative shareholders equity

Predictmedix Inc. Expands Reach and Impact in Healthcare Transformation Efforts

Predictmedix AI Inc. Unveils Technological Advances Including Publishing of Peer-Reviewed Paper

Third quarter 2024 earnings released: CA$0.003 loss per share (vs CA$0.004 loss in 3Q 2023)

Predictmedix Ai Inc. Elevates Safe Entry Stations with Cutting-Edge Facial Recognition Technology

Shareholders Will Probably Not Have Any Issues With Predictmedix AI Inc.'s (CSE:PMED) CEO Compensation

Predictmedix AI Inc. Announces Successful Clinical Validation At the University of Raharja, Indonesia, Demonstrating 95% Accuracy in Vital Sign Detection

First half 2024 earnings released: CA$0.009 loss per share (vs CA$0.006 loss in 1H 2023)

Predictmedix AI Inc., Annual General Meeting, Dec 07, 2023

Less than half of directors are independent

Predictmedix AI Inc. Unveils Cutting-Edge Contactless Integrative AI Solutions for Healthcare in India

Predictmedix Inc. announced that it has received CAD 1.051 million in funding

Predictmedix Inc. Advances Commercialization Plans for its AI-Powered Technology Suite in Key Asian Markets

Predictmedix Inc. announced delayed 20-F filing

Predictmedix Inc. Unveils Revolutionary Fitness Scan Vertical for Athletes, Teams, and Sports Federations

Predictmedix Launches Ai-Driven Comprehensive Triage Solution with Expanded Vital Parameter Measurements for High Traffic Hospitals in Targeted Asian Region

Predictmedix Inc. Announces Third-Party Independent Clinical Validation for Ai-Powered Screening Following 400 Patient Study at MGM Healthcare

Predictmedix Inc. announced that it has received CAD 0.6125 million in funding

High number of new directors

High number of new and inexperienced directors

Predictmedix Inc. announced a financing transaction

Predictmedix Inc. announced delayed 20-F filing

High number of new and inexperienced directors

Predictmedix Inc. Announces Accuracy Rates for Alcohol and Cannabis Impairment Detection Technology and Provides Update on the Next Steps for Technology Commercialization

President exercised options to buy CA$739k worth of stock.

Predictmedix Inc. announced that it has received CAD 1.090085 million in funding

Predictmedix Inc. Announces Safe Entry Stations to be deployed as a crucial, first line of defence at Tampa's VIP Big Game Weekend Parties

New 90-day low: CA$0.28

New 90-day low: CA$0.32

Wellness 4 Humanity Partners Set to Deploy and Offer Safe Entry Stations At Simon Mall’s Houston Galleria

Predictmedix Inc., Annual General Meeting, Jan 28, 2021

Predictmedix and Paras Defence & Space Technologies to Launch Predictmedix’s Proprietary Technologies in the Government and Public Sectors

New 90-day low: CA$0.43

New 90-day low: CA$0.48

New 90-day low - CA$0.48

Geschäftsführer